Volume 10

CellR4 2022; 10: e3332
DOI: 10.32113/cellr4_202210_3332

Safety study of cultured human Wharton’s Jelly mesenchymal stem cell therapy for multiple indications – a retrospective descriptive study

Mehling B. M.
BHI Therapeutic Sciences, Hackensack, NJ, USA
bmehling@bluehorizoninternational.com
, Wu D. C.
Department of Biochemistry and Molecular Biology, Wuhan University School of Basic Medical Sciences, Wuhan, China
, Santora D.
BHI Therapeutic Sciences, Hackensack, NJ, USA
, O’Gorman E.
BHI Therapeutic Sciences, Hackensack, NJ, USA
, Novakova K.
BHI Therapeutic Sciences, Hackensack, NJ, USA
, Spencer G.
Baywest Wellness Hospital and Clinics, Halfmoon Shopping Village, Rose Hall, Montego Bay, St. James, Jamaica
, Thomas C.
Baywest Wellness Hospital and Clinics, Halfmoon Shopping Village, Rose Hall, Montego Bay, St. James, Jamaica
, Grant R.
Baywest Wellness Hospital and Clinics, Halfmoon Shopping Village, Rose Hall, Montego Bay, St. James, Jamaica
, Rutherford R.
The Ohio State University, Columbus, OH, USA
, Mihályová R.
Blue Horizon International, Bratislava, Slovakia

CellR4 2022; 10: e3330
DOI: 10.32113/cellr4_202210_3330

Corrigendum – Targeting Toll-Like Receptor 4: a promising strategy to prevent type 1 diabetes occurrence or recurrence

Alibashe-Ahmed M.
Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland
, Berney T.
Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland
, Giovannoni L.
Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland
, Berishvili E.
Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland
Eberishvili@gmail.com

CellR4 2022; 10: e3322
DOI: 10.32113/cellr4_20228_3322

The cellular markers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific immune response

Kldiashvili E.
Petre Shotadze Tbilisi Medical Academy, Tbilisi, Georgia
e.kldiashvili@tma.edu.ge
, Iordanishvili S.
Petre Shotadze Tbilisi Medical Academy, Tbilisi, Georgia
, Shotadze T.
Petre Shotadze Tbilisi Medical Academy, Tbilisi, Georgia

CellR4 2022; 10: e3289
DOI: 10.32113/cellr4_20223_3289

Decreased Treg/Th17 ratio in Bulgarian patients after liver transplantation: a single-center experience

Mihova A. S.
Laboratory of Clinical Immunology, University Hospital Lozenets, Sofia, Bulgaria
, Peruhova M. M.
Clinic of Gastroenterology, University Hospital Lozenets, Sofia, Bulgaria
, Kukov A. D.
Laboratory of Clinical Immunology, University Hospital Lozenets, Sofia, Bulgaria
, Sekulovska-Peshevska M.
Clinic of Gastroenterology, University Hospital Lozenets, Sofia, Bulgaria
, Yurukova N. N.
Clinic of Gastroenterology, University Hospital Lozenets, Sofia, Bulgaria
, Ivanova I. L.
Laboratory of Clinical Immunology, University Hospital Lozenets, Sofia, Bulgaria
, Stancheva A. G.
Clinical Laboratory, University Hospital Lozenets, Sofia, Bulgaria
, Velikova T. V.
Laboratory of Clinical Immunology, University Hospital Lozenets, Sofia, Bulgaria
tsvelikova@medfac.mu-sofia.bg
, Altankova I. P.
Laboratory of Clinical Immunology, University Hospital Lozenets, Sofia, Bulgaria